Skip to content
zameds

Amlodipine (Amlodipine PD, Amloc, Besyloc, Tesdyn, Pearloc Plus)

Amlodipine

Pharma Dynamics (Pty) Ltd

Registration

Applicant
Pharma Dynamics (Pty) Ltd
Registrations
12

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Amlodipine 5 MG PD

EACH TABLET CONTAINS AMLODIPINE 10,0 mg

5 mg38014638/7.1/0146RegisteredNot determinedNone
Amloc 10 MG

EACH TABLET CONTAINS AMLODIPINE 10,0 mg

10 mg38014738/7.1/0147RegisteredNot determinedNone
Amloc 5 MG

EACH TABLET CONTAINS AMLODIPINE 5,0 mg

5 mg38018338/7.1/0183RegisteredNot determinedNone
Amlodipine 10 MG PD

EACH TABLET CONTAINS AMLODIPINE 10,0 mg

10 mg38018438/7.1/0184RegisteredNot determinedNone
Besyloc 5 MG

EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 5,0 mg

5 mg41056041/7.1/0560RegisteredNot determinedNone
Besyloc 10 MG

EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg

10 mg41056141/7.1/0561RegisteredNot determinedNone
Tesdyn 40/5 MG

EACH TABLET CONTAINS TELMISARTAN 40,0 mg AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 5,0 mg

40/5 mg55066855/7.1.3/0668RegisteredNot determinedNone
Tesdyn 40/10 MG

EACH TABLET CONTAINS TELMISARTAN 40,0 mg AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg

40/10 mg55066955/7.1.3/0669RegisteredNot determinedNone
Tesdyn 80/5 MG

EACH TABLET CONTAINS TELMISARTAN 80,0 mg AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 5,0 mg

80/5 mg550670RegisteredNot determinedNone
Tesdyn 80/10 MG

EACH TABLET CONTAINS TELMISARTAN 80,0 mg AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg

80/10 mg55067155/7.1.3/0671RegisteredNot determinedNone
Pearloc plus 4/1,25/5 MG

EACH TABLET CONTAINS: PERINDOPRIL ERBUMINE 4,0 mg INDAPAMIDE 1,25 mg AMLODIPINE BESILATE EQUIVALENT TO AMLODIPINE 5,0 mg

4/1,25/5 mg59000959/7.1.3/0009RegisteredNot determinedNone
Pearloc plus 8/2,5/5 MG

EACH TABLET CONTAINS: PERINDOPRIL ERBUMINE 8,0 mg INDAPAMIDE 2,5 mg AMLODIPINE BESILATE EQUIVALENT TO AMLODIPINE 5,0 mg

8/2,5/5 mg59001059/7.1.3/0010RegisteredNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

  • S3: Amlodipine

    Consolidated Schedules 06 July 2026, line 3138

  • S3: Indapamide

    Consolidated Schedules 06 July 2026, line 3780

  • S3: Irbesartan

    Consolidated Schedules 06 July 2026, line 3806

  • S3: Telmisartan

    Consolidated Schedules 06 July 2026, line 4286

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C20H25ClN2O5408.90 g/mol

3-O-Ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate

Drag to rotate. Structure from PubChem CID 2162.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles